NFKB1 and breast cancer: In another study, arctigen exerted anti-metastatic effects on both MCF-7 and MDA-MB-231 human breast cancer cell lines by inhibiting the NF-κB, Akt/MAPK signaling pathways, and MMP-9 [42] (Table 1).